Dr.Agarwals Eye Hospital Ltd.

Web: dragarwal.com NSE: DRAGARWQ BSE: 526783 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

5328 12(0%)

Volume

1k as on 23, Jun

Open

5,604

High

5,604

Low

5,514

5,339

VWAP

5,038

52 Week High

6,060

52 Week Low

4,600

Viand Research Rating

Quality Score

69/100

Growth Score

64/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,575

No. of Shares

0.48

P/E

47.59

P/B

15.29

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

32.13

ROCE

Profit Growth

Listing Date

Promoter Holding

72.67%

FII Holding

2.24%

DII Holding

2.05%

Price Chart

Price Performance

1 Week1%

1 Month3%

3 Months5%

6 Months5%

1 Year5%

YTD5%

Moving Average

5 Day SMA5,004

10 Day SMA4,978

20 Day SMA5,024

30 Day SMA5,044

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	5,161	5,057	5,118	5,142
Resistance 2	5,118	5,050	5,086	5,108
Resistance 1	5,076	5,042	5,065	5,057
Pivot Point	5,033	5,034	5,033	5,024
Support 1	4,991	5,026	5,001	4,972
Support 2	4,948	5,018	4,980	4,938
Support 3	4,906	5,011	4,948	4,887

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 72.67%	(0.01) 72.67%	(0.01) 72.67%	(0.81) 72.67%	(0.01) 71.90%	(0.01) 71.90%	(0.01) 71.90%	(0.01) 71.90%	(0.01) 71.90%	(0.01) 71.89%	(0.01) 71.89%	(0.01) 71.89%	(0.01) 71.89%	(0.01) 71.89%	(0.01) 71.89%	(-0.11) 71.90%	(-0.21) 72.00%	(-0.21) 72.15%	(0.01) 72.38%
FIIs	(0.01) 2.24%	(0.41) 2.20%	(0.11) 1.82%	(0.31) 1.74%	(0.21) 1.49%	(0.51) 1.33%	(0.01) 0.84%	(0.21) 0.83%	(0.01) 0.65%	(0.01) 0.64%	(0.41) 0.63%	(0.31) 0.28%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(-0.11) 2.05%	(-0.21) 2.12%	(0.01) 2.36%	(0.01) 2.36%	(0.41) 2.31%	(0.91) 1.95%	(0.11) 1.04%	(1.01) 0.96%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	23.03%	22.99%	23.15%	23.22%	24.29%	24.82%	26.22%	26.32%	27.46%	27.47%	27.47%	27.82%	28.10%	28.10%	28.10%	28.09%	28.00%	27.85%	27.62%
No. of Shareholders	22,954	24,036	25,449	30,528	35,976	41,704	15,115	4,510	3,808	3,572	3,423	3,471	3,169	3,110	3,006	2,858	2,791	2,764	2,741

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	143	120	116	118	117	100	95	102	100	81	76	84	79	69	64	69	66	56	56	58
Sales Growth % (YoY)	22.3%	20.2%	22.2%	15.2%	16.9%	23.7%	25.2%	21.5%	27.3%	16.3%	19.5%	22.3%	18.3%	24.7%	12.5%	18.1%	115.1%	7.6%	32.2%	91.8%
Sales Growth % (QoQ)	19.2%	3.4%	-1.7%	0.9%	17%	5.3%	-6.9%	2%	23.5%	6.6%	-9.5%	6.3%	14.5%	7.8%	-7.2%	4.5%	17.9%	-	-3.4%	-
Expenses	100	86	82	78	80	68	69	72	69	56	55	61	56	48	48	50	47	39	40	39
Operating Profit	43	34	34	40	37	32	26	30	31	24	21	23	23	21	15	19	20	16	17	19
OPM %	30	28	30	34	32	32	27	29	31	30	27	28	29	30	24	27	30	29	30	33
Other Income	2	2	3	1	1	0	2	2	0	2	1	1	0	0	0	1	0	0	0	0
Interest	3	2	2	4	4	3	4	4	3	2	2	2	2	2	2	1	2	2	2	2
Depreciation	11	12	12	11	11	10	10	9	10	8	7	6	6	2	7	6	6	6	5	5
Profit before tax	31	21	23	26	23	19	14	19	19	17	13	17	16	18	7	12	12	9	11	13
Tax %	24	24	26	25	26	14	26	26	25	26	26	24	26	25	24	27	25	26	25	25
Net Profit	23	16	17	19	17	16	10	14	14	13	9	13	12	14	5	9	9	7	8	10
Net Profit Growth % (QoQ)	43.8%	-5.9%	-10.5%	11.8%	6.2%	60%	-28.6%	-	7.7%	44.4%	-30.8%	8.3%	-14.3%	180%	-44.4%	-	28.6%	-12.5%	-20%	-
Net Profit Growth % (YoY)	35.3%	-	70%	35.7%	21.4%	23.1%	11.1%	7.7%	16.7%	-7.1%	80%	44.4%	33.3%	100%	-37.5%	-10%	-	-	-	-
TTM Net Profit	75	69	69	62	57	54	51	50	49	47	48	44	40	37	30	33	34	25	18	0
EPS in Rs	48.38	33.6	35.76	39.98	36.72	34.02	22.13	30.11	30.02	27.21	20.09	26.79	24.55	29.11	10.77	19.3	19.38	14.62	17.34	20.87

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	471	397	319	268	201	140	176	170	153	149	137	118	113	109
Sales Growth %	18.6%	24.4%	19.1%	33.2%	43.9%	-20.5%	3.5%	10.9%	3.2%	8.8%	15.6%	4.9%	3.8%	4.8%
Expenses	326	277	227	192	143	109	129	140	129	126	119	103	102	96
Operating Profit	145	120	92	76	59	31	47	30	24	23	18	15	11	12
OPM %	31	30	29	28	29	22	27	18	16	15	13	13	9	11
Other Income	6	5	5	2	1	1	3	2	2	1	-5	0	3	1
Interest	12	15	8	8	7	7	9	4	3	4	5	4	4	4
Depreciation	46	39	27	20	20	19	21	11	10	9	9	6	6	5
Profit before tax	94	71	62	49	32	6	20	17	13	11	0	5	4	4
Tax %	25	23	26	25	25	125	31	32	49	33	-104	-6	35	29
Net Profit	70	55	46	37	24	-1	14	12	7	7	0	6	2	3
Net Profit Growth %	27.3%	19.6%	24.3%	54.2%	2500%	-107.1%	16.7%	71.4%	-	-	-100%	200%	-33.3%	-
EPS in Rs	145.05	116.28	98.64	78.55	51.28	-3.06	29.11	25.36	14.43	15.62	0.09	12.13	5.17	6.98
Dividend Payout %	3	5	3	4	6	0	0	6	8	10	940	10	23	17

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	145	94	90	70	57	34	39	25	19	20	17	14	12	11
Cash from Investing Activity	-174	-133	-70	-71	-46	-11	-17	-25	-11	-8	-17	-10	-11	-6
Cash from Financing Activity	25	17	-14	0	-4	-8	-20	2	-8	-12	0	-5	-3	-3
Net Cash Flow	-4	-22	6	-1	7	15	2	2	0	0	0	-1	-2	2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	4
Reserves	341	310	205	179	152	109	73	50	51	41	30	25	19	19	14	11
Borrowings	326	335	333	305	268	232	193	68	60	24	18	23	31	27	28	28
Other Liabilities	94	79	71	80	71	44	42	33	24	31	28	20	24	18	20	19
Total Liabilities	766	729	613	569	496	390	314	155	141	100	81	72	79	69	67	63
Fixed Assets	403	409	393	364	316	260	214	96	94	55	36	33	34	26	26	23
CWIP	197	157	128	114	97	62	26	0	0	0	3	1	1	0	0	0
Investments	89	85	13	13	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	78	79	80	78	83	67	73	60	47	45	42	38	44	43	41	41
Total Assets	766	729	613	569	496	390	314	155	141	100	81	72	79	69	67	63

Delivery

Delivery Data: DRAGARWQ

#	Date	4814 16% 5600	Value (Cr)	Q/T 5	Del 67	Del 1
1	4-Sep	5422	1	5	81	0
2	3-Sep	5339	1	3	54	0
3	2-Sep	5420	1	2	55	1
4	1-Sep	5310	0	2	59	0
5	31-Aug	5266	1	5	84	1
6	28-Aug	5246	0	3	46	0
7	27-Aug	5176	1	3	57	0
8	26-Aug	5246	1	3	49	0
9	25-Aug	5328	0	4	56	0
10	24-Aug	5374	0	3	61	0
11	21-Aug	5395	1	3	60	0
12	20-Aug	5307	0	4	82	0
13	19-Aug	5328	1	3	45	0
14	18-Aug	5321	0	3	65	0
15	17-Aug	5294	1	5	72	0
16	14-Aug	5403	1	4	71	1
17	13-Aug	5418	1	4	61	1
18	12-Aug	5312	2	4	55	1
19	11-Aug	5314	0	3	74	0
20	10-Aug	5386	1	4	57	1
21	7-Aug	5286	1	4	73	1
22	6-Aug	5253	1	3	71	1
23	5-Aug	5197	1	5	66	1
24	4-Aug	5081	3	4	46	2
25	3-Aug	5007	1	7	79	1
26	31-Jul	5022	0	3	62	0
27	30-Jul	4994	0	3	72	0
28	29-Jul	5006	0	5	81	0
29	28-Jul	5052	0	3	64	0
30	27-Jul	5042	0	3	63	0
31	24-Jul	5022	0	2	70	0
32	23-Jul	5016	0	3	77	0
33	22-Jul	5034	0	3	69	0
34	21-Jul	5012	0	2	65	0
35	20-Jul	5006	0	2	48	0
36	17-Jul	5016	0	3	71	0
37	16-Jul	4952	0	3	58	0
38	15-Jul	5084	0	2	58	0
39	14-Jul	5008	0	2	66	0
40	13-Jul	4997	1	2	68	0
41	10-Jul	4902	0	3	74	0
42	9-Jul	5012	0	2	56	0
43	8-Jul	4908	1	3	68	1
44	7-Jul	4996	0	2	66	0
45	6-Jul	5000	0	4	89	0
46	3-Jul	5027	1	3	63	0
47	2-Jul	5078	0	2	53	0
48	1-Jul	5049	0	2	61	0
49	30-Jun	5094	1	3	62	0
50	29-Jun	5004	0	3	65	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,575c	16c	0.61
03-Sep	2,590c	30c	1.15
01-Sep	2,561c	16c	0.65
31-Aug	2,545c	55c	2.21
27-Aug	2,489c	89c	3.45
26-Aug	2,578c	4c	0.17
25-Aug	2,583c	18c	0.70
24-Aug	2,601c	48L	0.02
21-Aug	2,601c	22c	0.83
19-Aug	2,580c	16c	0.61
18-Aug	2,564c	39c	1.51
17-Aug	2,603c	20c	0.75
14-Aug	2,623c	36c	1.40
13-Aug	2,587c	57c	2.15
12-Aug	2,644c	34c	1.31
11-Aug	2,610c	0	0
10-Aug	2,610c	65c	2.55
06-Aug	2,545c	73c	2.95
04-Aug	2,472c	49c	2.01
03-Aug	2,423c	1c	0.05
31-Jul	2,422c	10c	0.43
30-Jul	2,432c	8c	0.33
29-Jul	2,424c	4c	0.15
28-Jul	2,420c	20c	0.83
27-Jul	2,441c	0	0

Stock Checklist

Price is above from 52 week high low average: 50%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹1 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
PGIM India Mutual Fund	4	0.47%	-0.03%	1.5
Bandhan Mutual Fund	2	0.05%	-	0

Dr.Agarwals Eye Hospital Ltd.

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements